AnaManzanoAparicioMD

Clinical Trials

• Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer Start of enrollment: 2006 May 01

  Completed

  Phase 2

• Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma Start of enrollment: 2007 Oct 01

  Terminated

  Phase 2

• Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2016 May 18

  Active, not recruiting

  Phase 2

• Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC Start of enrollment: 2017 Oct 03

  Active, not recruiting

  Phase 2

• Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer Start of enrollment: 2020 Dec 29

  Active, not recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers Start of enrollment: 2020 Aug 20

  Recruiting

  Phase 1

  Roles: Contact, Principal Investigator

• Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) Start of enrollment: 2024 Feb 29

  Recruiting

  Phase 1, Phase 2

  Roles: Contact, Principal Investigator

• Join now to see all